Evidence map›Paper›PMID 32862153›Full record

ArticleAging2020

Flavonoids from

Sai-Juan Xu, Xia Wang, Tao-Yang Wang, Zheng-Zhan Lin, Yong-Jian Hu, Zhong-Lin Huang, Xian-Jun Yang, Ping Xu

Open access · greenAbstract readComparative Study
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cili (Current issues in molecular biology · 2026
    Review
  5. Review
  6. Flavonoids inFood science & nutrition · 2025
    Article
  7. The Phytochemical Characterization of a Cili (Foods (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sai-Juan XuDepartment of Pharmacy, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Xia WangCollege of Medical Laboratory, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Tao-Yang WangHenan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Zheng-Zhan LinDepartment of Pharmacy, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Yong-Jian HuHenan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Zhong-Lin HuangHenan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Xian-Jun YangInternational Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Ping XuHenan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the role of FRT in ROS/DNA regulation with or without PARP-1 in radiation-injured thymus cells. The administration of FRT to PARP-1-/- (KO) mice demonstrated that FRT significantly increased the viability of thymus cells and decreased their rate of apoptosis through PARP-1. Radiation increased the levels of ROS, γ-H2AX and 53BP1, and induced DNA double strand breaks. Compared with wild type (WT) mice, levels of ROS, γ-H2AX and 53BP1 in KO mice were much less elevated. The FRT treatment groups also showed little reduction in these indicators in KO mice compared with WT mice. The results of the KO mice study indicated that FRT reduced ROS activation through inhibition of PARP-1. Furthermore, FRT reduced the concentrations of γ-H2AX by decreasing ROS activation. However, we found that FRT did not regulate 53BP1, a marker of DNA damage, because of its elimination of ROS. Levels of apoptosis-inducing factor (AIF), exhibited no significant difference after irradiation in KO mice. To summarize, ROS suppression by PARP-1 knockout in KO mice highlights potential therapeutic target either by PARP-1 inhibition combined with radiation or by treatment with a drug therapy alone. AIF-induced apoptosis could not be activated in KO mice.

Indexed as

RosaAnimalsAntioxidantsApoptosisApoptosis Inducing FactorCells, CulturedDNA Breaks, Double-StrandedFlavonoidsHistonesMice, KnockoutOxidative StressPoly (ADP-Ribose) Polymerase-1Reactive Oxygen SpeciesThymus GlandTumor Suppressor p53-Binding Protein 1AIFM1 protein, mouseAntioxidantsApoptosis Inducing FactorFlavonoidsgamma-H2AX protein, mouseHistonesParp1 protein, mousePoly (ADP-Ribose) Polymerase-1Reactive Oxygen SpeciesTrp53bp1 protein, mouseTumor Suppressor p53-Binding Protein 1flavonoids of Rosa roxburghii Trattmice thymusPARP-1/AIFradioprotective effectROS/DNA

Identifiers

PMID32862153
PMCPMC7485694
OpenAlexW3080446236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.